Sanitor Corporation – FDA 483, Apr 14, 2023
Sanitor Corporation, a contract drug manufacturer in Stanton, CA, was cited for five significant deficiencies during an FDA inspection. The observations highlight systemic issues including inadequate quality control unit procedures, compromised data integrity due to poor computer system controls and backup processes, and widespread failures in employee cGMP training. Additionally, the firm failed to establish appropriate storage conditions based on stability testing and maintained inadequate environmental controls for drug products and raw materials.
ID · 7d4a7f25-e6f5-4398-91e7-1d17e0aa2be4
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.